# Clinical Trial of HIV Vaccine Combinations in Healthy Men and Women

> **NCT03408262** · PHASE1 · COMPLETED · sponsor: **Imperial College London** · enrollment: 68 (actual)

## Conditions studied

- Human Immunodeficiency Virus

## Interventions

- **BIOLOGICAL:** Ad4-EnvCN54
- **BIOLOGICAL:** MVA-CN54
- **BIOLOGICAL:** CN54gp140/MPLA

## Key facts

- **NCT ID:** NCT03408262
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-06
- **Primary completion:** 2020-02-10
- **Final completion:** 2020-02-10
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2024-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03408262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03408262, "Clinical Trial of HIV Vaccine Combinations in Healthy Men and Women". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03408262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*